News
- - News
Entertainment
- - Funny & Gags
  - Gossip
Business
- - Business
Sports
- - Sports
Science & Tech
- - Tech
  - Science

Natco Pharma locked at 20% upper circuit as partner Mylan gets USFDA nod for multiple sclerosis drug

News / News 7 years ago 589 Views comments

The firm projects PAT CAGR of 28 percent over three years.

Source:
Moneycontrol Latest News

facebook
twitter
Whatsapp
google+
linkedin
email

Paid Prime Membership on Primevideo.com

Previous post

Godrej Agrovet IPO opens. Should you subscribe to the issue?

Next post

OMCs open in green, HPCL jumps over 3% after cut in excise duty on petrol diesel

Comments

Related Posts

Here is a fundamental view on the market from Nischal Maheshwari

News / News - 7 years ago

Liberal Democrats leader: A UK-India FTA is not going to happen

News / News - 7 years ago

RBI rejects lenders#39; plea to extend deadline for stake sale in GMR power plant

News / News - 7 years ago

Cyclone Ockhi heads to Maharashtra: Precautionary holiday for schools colleges

News / News - 7 years ago

During 3-year tenure, NDA spends twice more than UPA in print, electronic advertising: RTI

News / News - 7 years ago

Cabinet Reshuffle: The appointments that matter

News / News - 7 years ago

RIVER Collection launch: Latest styles from your favourite designers | Made for Amazon | Up to 20% off - Launching on 1st

Follow @truearacom

TrueAra

Pages

Popular Tweets
Privacy
Terms Of Use

Categories

Living
Movies

Follow us

Copyright 2016-2017 Content Aggregator All rights reserved.

No results found.

Home
News
- News
Entertainment
- Funny & Gags
- Gossip
Business
- Business
Sports
- Sports
Science & Tech
- Tech
- Science